BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34763667)

  • 21. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
    Li G; Zhu Y
    Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.
    Adamski J; Price A; Dive C; Makin G
    PLoS One; 2013; 8(6):e65304. PubMed ID: 23785417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
    Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
    Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
    Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
    Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression.
    Hu K; Xie W; Ni S; Yan S; Tian G; Qi W; Duan Y
    Oncol Rep; 2020 Aug; 44(2):650-660. PubMed ID: 32627005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
    Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
    J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
    Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer.
    Li Z; Zhou W; Zhang Y; Sun W; Yung MMH; Sun J; Li J; Chen CW; Li Z; Meng Y; Chai J; Zhou Y; Liu SS; Cheung ANY; Ngan HYS; Chan DW; Zheng W; Zhu W
    Clin Cancer Res; 2019 Oct; 25(19):5947-5960. PubMed ID: 31285371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.
    Gómez V; Eykyn TR; Mustapha R; Flores-Borja F; Male V; Barber PR; Patsialou A; Green R; Panagaki F; Li CW; Fruhwirth GO; Ros S; Brindle KM; Ng T
    Sci Signal; 2020 Oct; 13(652):. PubMed ID: 33023985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
    Fellenberg J; Kunz P; Sähr H; Depeweg D
    PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α.
    Keremu A; Aini A; Maimaitirexiati Y; Liang Z; Aila P; Xierela P; Tusun A; Moming H; Yusufu A
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 28442599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
    Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
    J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
    McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
    BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
    Ruiz MC; Resasco A; Di Virgilio AL; Ayala M; Cavaco I; Cabrera S; Aleman J; León IE
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):681-692. PubMed ID: 30661096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced resistance to cisplatin-mediated apoptosis in osteosarcoma cells is reversed by gambogic acid independently of HIF-1α.
    Zhao W; Xia SQ; Zhuang JP; Zhang ZP; You CC; Yan JL; Xu GP
    Mol Cell Biochem; 2016 Sep; 420(1-2):1-8. PubMed ID: 27473145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
    Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
    Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.